Tyra Biosciences, Inc. TYRA Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Tyra Biosciences, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tyra Biosciences, Inc.'s cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tyra Biosciences, Inc.'s cash ratio?
- Tyra Biosciences, Inc. (TYRA) reported cash ratio of 4.4× in Q1 2026.
- How has Tyra Biosciences, Inc.'s cash ratio changed year-over-year?
- Tyra Biosciences, Inc.'s cash ratio decreased by 37.6% year-over-year, from 7.1× to 4.4×.
- What is the long-term trend for Tyra Biosciences, Inc.'s cash ratio?
- Over 5 years (2020 to 2025), Tyra Biosciences, Inc.'s cash ratio has grown at a -12.2% compound annual growth rate (CAGR), from 8.2× to 4.3×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.